It is well established that the TP53 tumor suppressor protein is frequently mutated in cancer.[21, 22] TP53 mutations have been found to confer a poor prognosis in several tumor types.[23-25] Most studies report that the TP53 is mutated in about 30% of breast cancers. This evidence concerns the gene TCHP and neoplasm.